Results 1 to 10 of about 44,370 (261)

Improvements With Tiotropium Maintenance Therapy in COPD Patients Without Dyspnea. [PDF]

open access: yesMedComm (2020)
In a post hoc analysis of the Tie‐COPD trial, including 305 patients with mild‐to‐moderate COPD and no dyspnea (mMRC 0), 2 years of tiotropium improved lung function, lowered the annual exacerbation rate, and delayed the first clinically important deterioration, indicating benefit beyond symptom relief in a group not currently offered maintenance ...
Wang Z   +15 more
europepmc   +2 more sources

Updates in COPD Management: From Inflammatory Pathways to Targeted Therapies. [PDF]

open access: yesEur J Clin Invest
COPD is a heterogeneous disease driven by overlapping neutrophilic and eosinophilic inflammatory pathways. This review highlights the shift from symptom‐based treatment toward phenotype‐ and biomarker‐directed care. Blood eosinophils, FeNO, and IgE predict corticosteroid responsiveness and identify candidates for biologic therapy.
Raman S   +3 more
europepmc   +2 more sources

Associations of current and life-course smoking and indoor environmental exposures with lung function level in early adulthood. [PDF]

open access: yesEnviron Epidemiol
Hendrickx DM   +7 more
europepmc   +1 more source

Long term outcome following pulmonary TB or lower respiratory tract illness in children: a prospective South African study. [PDF]

open access: yesEClinicalMedicine
Chaya S   +10 more
europepmc   +1 more source

Pre-COPD, PRISm, and COPD in young adults born preterm. [PDF]

open access: yesAnn Am Thorac Soc
Smith EF, Lavery C, Simpson SJ.
europepmc   +1 more source

Impaired lung function and bronchodilator responsiveness in former very preterm infants at preschool age: associated factors and clinical implications. [PDF]

open access: yesFront Pediatr
Höck M   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy